ZyVersa Therapeutics Inc. (ZVSA)
NASDAQ: ZVSA
· Real-Time Price · USD
0.31
-0.24 (-43.53%)
At close: Jul 16, 2025, 3:59 PM
-43.53% (1D)
| Bid | 0.27 |
| Market Cap | 1.48M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -4.66B |
| EPS (ttm) | -4.68 |
| PE Ratio (ttm) | -0.07 |
| Forward PE | -0.01 |
| Analyst | Strong Buy |
| Ask | 0.31 |
| Volume | 9,010,564 |
| Avg. Volume (20D) | 5,593,145 |
| Open | 0.55 |
| Previous Close | 0.55 |
| Day's Range | 0.27 - 0.56 |
| 52-Week Range | 0.27 - 5.22 |
| Beta | 0.74 |
About ZVSA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ZVSA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ZVSA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
ZyVersa Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
3 months ago
ZyVersa Therapeutics shares are trading higher after the company announced developments for its inflammasome inhibitors.
